- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02603731
Delirium at the Intensive Care Unit - a Retrospective Cohort Study
This project seeks to describe the incidence of delirium in the Intensive Care Unit (ICU) and to identify risk and preventive factors associated with development of delirium.
Especially, the investigators want to investigate if an imitated natural light/dark cycle influences frequency of delirium.
Study Overview
Status
Conditions
Detailed Description
A common problem for patients in the ICU is episodes of delirium. Recent trials have described incidences ranging from 60-87% of patients in a number of different countries. Delirium is a condition with fluctuating conscience, disorganized thinking and disturbance of the sleep/wake cycle. Many patients with delirium experience hallucinations and agitation which can be very unpleasant for both patients and their families.
Some risk factors for the development of delirium well known, e.g. dementia, hypertension, illness severity (SAPS II score), delirium on the previous day, mechanical ventilation, emergency surgery and metabolic acidosis. The effect of sedative drug administration is not clear, as studies has been inconclusive.
Even though studies regarding the impact of sleep deprivation on development of delirium have been inconclusive, there is no doubt that delirious patients have a disturbed sleep-wake cycle, sleep architecture and circadian rhythm.
At the intensive care unit at the Department of Anesthesiology at Køge Hospital, three out of nine rooms have a simulated circadian light installed. The idea is that this light rhythm may help to keep a natural circadian rhythm, minimizing the risk of delirium.
With this descriptive and retrospective cohort study, the investigators therefore want to describe the incidence and possible risk- and preventive factors of delirium for the participants (ICU patients at Køge Hospital), and with a special focus on the possible effect of imitated circadian light..
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Køge, Denmark
- Køge Sygehus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients >18 years of age admitted to the ICU at Køge Hospital in the study period
Exclusion Criteria:
- Richmond Agitation Sedation Score (RASS): -4 or -5 during the whole study period
- No CAM-ICU scores during the ICU stay
- Unable to communicate in Danish (aphasic, deaf, non-Danish speaking, severe brain damage)
- Severe dementia documented in electronic patient charts (OPUS)
- Patients not receiving active treatment (moribund patients)
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Delirium at any time point
Time Frame: Throughout study period, up to 6 months
|
Incidence of patients with delirium during ICU-stay defined as at least one positive Confusion Assessment Method for the ICU (CAM-ICU) score or CAM-ICU negative delirium treated with anti-psychotics.
|
Throughout study period, up to 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Days with delirium
Time Frame: Throughout study period, up to 6 months
|
Days with positive CAM-ICU or CAM-ICU negative delirium treated with anti-psychotics in relation to length of stay (LOS)
|
Throughout study period, up to 6 months
|
|
Circadian light exposure
Time Frame: Throughout study period, up to 6 months
|
Difference in incidences of delirium between patients admitted to rooms with circadian rhythm lighting and standard rooms
|
Throughout study period, up to 6 months
|
|
Delirium in patients treated with hypnotics
Time Frame: Throughout study period, up to 6 months
|
Difference in incidence of delirium in patients treated with hypnotics before admission to hospital (ATC N05C) compared to those who are not
|
Throughout study period, up to 6 months
|
|
Delirium in patients treated with steroids
Time Frame: Throughout study period, up to 6 months
|
Differences in incidences of delirium in patients that are treated with systemic steroids vs. no treatment
|
Throughout study period, up to 6 months
|
|
Mortality
Time Frame: Throughout study period, up to 6 months
|
Mortality within ICU stay
|
Throughout study period, up to 6 months
|
|
Demographic differences
Time Frame: Throughout study period, up to 6 months
|
Incidence of delirium associated to demographic variables (age, gender)
|
Throughout study period, up to 6 months
|
|
Delirium and Simplified Acute Physiology Score (SAPS)
Time Frame: Throughout study period, up to 6 months
|
Incidence of delirium associated to Simplified Acute Physiology Score (SAPS) II
|
Throughout study period, up to 6 months
|
|
Delirium related to number of ventilator days
Time Frame: Throughout study period, up to 6 months
|
Incidence of delirium associated to number of ventilator days
|
Throughout study period, up to 6 months
|
|
Delirium related to sedation
Time Frame: Throughout study period, up to 6 months
|
Incidence of delirium associated to sedation infusion
|
Throughout study period, up to 6 months
|
|
Delirium related to admission type
Time Frame: Throughout study period, up to 6 months
|
Incidence of delirium associated to admission type (medical/elective surgical/acute surgical)
|
Throughout study period, up to 6 months
|
|
Distribution of types of delirium
Time Frame: Throughout study period, up to 6 months
|
Incidence and distribution of delirium subtypes (hypoactive/hyperactive/mixed)
|
Throughout study period, up to 6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Ole Mathiesen, MD, PhD, Køge Hospital
Publications and helpful links
General Publications
- Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, Brummel NE, Hughes CG, Vasilevskis EE, Shintani AK, Moons KG, Geevarghese SK, Canonico A, Hopkins RO, Bernard GR, Dittus RS, Ely EW; BRAIN-ICU Study Investigators. Long-term cognitive impairment after critical illness. N Engl J Med. 2013 Oct 3;369(14):1306-16. doi: 10.1056/NEJMoa1301372.
- Ely EW, Margolin R, Francis J, May L, Truman B, Dittus R, Speroff T, Gautam S, Bernard GR, Inouye SK. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001 Jul;29(7):1370-9. doi: 10.1097/00003246-200107000-00012.
- Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, Hart RP, Dittus R. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001 Dec 5;286(21):2703-10. doi: 10.1001/jama.286.21.2703.
- Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, Gordon SM, Canonico AE, Dittus RS, Bernard GR, Ely EW. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med. 2010 Jul;38(7):1513-20. doi: 10.1097/CCM.0b013e3181e47be1.
- Svenningsen H, Tonnesen EK, Videbech P, Frydenberg M, Christensen D, Egerod I. Intensive care delirium - effect on memories and health-related quality of life - a follow-up study. J Clin Nurs. 2014 Mar;23(5-6):634-44. doi: 10.1111/jocn.12250. Epub 2013 May 6.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SE-DELIR1-15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Delirium
-
Alexandria UniversityCompletedClozapine Poisoning | Hypoactive Delirium | Tricyclic Antidepressant Poisoning | Anticholinergic Delirium | Antipsychotic Toxicity | CNS Depression | Procyclidine Induced DeliriumEgypt
-
Efficacy Care R&D LtdHadassah Medical OrganizationUnknownDelirium | Delirium, Cause Unknown | Delirium of Mixed Origin | Delirium Confusional State | Delirium Drug-InducedIsrael
-
Duke UniversityNot yet recruitingDelirium Confusional State | Hyperactive Delirium | Delirium in the Intensive Care Unit | Agitated DeliriumUnited States
-
Sengkang General HospitalRecruitingDelirium and Post-operative Cognitive Dysfunction (POCD) | Delirium, Postoperative | Delirium - PostoperativeSingapore
-
Imperial College Healthcare NHS TrustRecruitingCardiac Surgery | Intensive Care Unit Delirium | Post Operative DeliriumUnited Kingdom
-
Oslo University HospitalUniversity of Melbourne; Norwegian Academy of MusicCompletedDelirium in Old Age | Delirium of Mixed Origin | Delirium Superimposed on Dementia | Delirium Confusional StateNorway
-
Universitat de LleidaHospital d'IgualadaNot yet recruitingDelirium in Old Age | Delirium Treatment | Delirium Confusional StateSpain
-
Universidad de SantanderUnknownDelirium of Mixed Origin | Hypoactive Delirium | Hyperactive DeliriumColombia
-
Wonkwang University HospitalCompleted
-
Second Affiliated Hospital of Wenzhou Medical UniversityAffiliated Wenling Hospital of Wenzhou Medical UniversityRecruitingInjection | Delirium in Old Age | Post Operative Delirium | Non-cardiac SurgeryChina